The field of Fecal Microbiota Transplant (FMT) discussed by Dr Jannie G.E. Henderickx , Dr Andrea Aira Gómez and Chelsea Bickley from Biomebank sharing their work within this subject.
Dr Jannie G.E. Henderickx
Multi-kingdom interactions in Clostridioides difficile colonization and infection
Dr. Jannie G.E. Henderickx is a postdoctoral researcher and study coordinator at the Centre for Microbiome Analyses and Therapeutics (CMAT) at Leiden University Medical Centre. Jannie performed her PhD research at the Microbiology department of Wageningen University & Research, investigating the early life microbiome of preterm infants. Within her current research, Jannie aims to uncover the human microbiome’s clinical potential. Bioinformatic approaches allow her to study the ecology and functions of bacteria and fungi constituting the human microbiome in a wide spectrum of disease states.
Anaerobic manufacturing of first-in-class microbiome drug product
Chelsea Bickley has always been passionate about helping people through science ever since she was young. In 2010 she completed her studies at Flinders University in Adelaide Australia, with a major in Biochemistry and an Honours degree. After a few years in the workforce, she joined CSIRO in the middle of 2014 and was there for several years. During her time at CSIRO she met one of the founders of BiomeBank, Sam Costello and assisted in the lab-work for his PhD on FMT for the treatment of Ulcerative Colitis igniting her interest in the field. After her time at CSIRO ended, she joined BiomeBank and has been there since 2020 and assumed the Head of Production title in 2021.
Dr Andrea Aira Gómez
Microbiota-associated metabolites and their interactions with the gut-brain axis
Microbiologist, PhD in Medicine and Translational research with experience in FMT implementation in clinical settings including stool donor selection, sample processing and stool banking.
Event hosted and organised by Don Whitley Scientific Limited.